BEAR CERTIFICATE - ROCHE GS Share Price

Certificat

RGJABP

CH1109612551

Real-time Bid/Ask 04:11:20 03/06/2024 pm IST
4.86 CHF / 4.91 CHF -0.91% Intraday chart for BEAR CERTIFICATE - ROCHE GS
1 month-25.42%
3 months-27.71%
Date Price Change
31/24/31 4.93 -6.98%
30/24/30 5.3 +1.92%
29/24/29 5.2 -0.19%
28/24/28 5.21 +1.96%
27/24/27 5.11 +1.59%

Delayed Quote Swiss Exchange

Last update May 31, 2024 at 08:50 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellPUT
Underlying ROCHE HOLDING AG
IssuerLogo Issuer BNP Paribas BNP Paribas
RGJABP
ISINCH1109612551
Date issued 31/05/2021
Maturity Unlimited
Parity 1 : 1
Emission price- CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 8.06 CHF
Lowest since issue 1.49 CHF
Spread 0.05 CHF
Spread %1.02%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
231 CHF
Average target price
277.5 CHF
Spread / Average Target
+20.14%
Consensus
  1. Stock Market
  2. Certificates
  3. RGJABP Certificat